Peer reviewers for the major medical journals received $1.2 billion from drug and device companies from 2020 to 2022. 59% of all reviewers. Peer review is dead. https://jamanetwork.com/journals/jama/fullarticle/2824834
See Tweet
Peer reviewers for the major medical journals received $1.2 billion from drug and device companies from 2020 to 2022. 59% of all reviewers. Peer review is dead. https://jamanetwork.com/journals/jama/fullarticle/2824834
See Tweet